SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-066362
Filing Date
2021-12-20
Accepted
2021-12-20 16:30:46
Documents
13
Period of Report
2021-12-15
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea152569-8k425_orion.htm   iXBRL 8-K 39779
  Complete submission text file 0001213900-21-066362.txt   271801

Data Files

Seq Description Document Type Size
2 XBRL DEFINITION FILE oria-20211215_def.xml EX-101.DEF 27522
3 XBRL LABEL FILE oria-20211215_lab.xml EX-101.LAB 38242
4 XBRL PRESENTATION FILE oria-20211215_pre.xml EX-101.PRE 26136
5 XBRL SCHEMA FILE oria-20211215.xsd EX-101.SCH 4332
7 EXTRACTED XBRL INSTANCE DOCUMENT ea152569-8k425_orion_htm.xml XML 7533
Mailing Address 645 FIFTH AVENUE, 21ST FLOOR NEW YORK NY 10022
Business Address 645 FIFTH AVENUE, 21ST FLOOR NEW YORK NY 10022 212-303-7822
Orion Biotech Opportunities Corp. (Filer) CIK: 0001847416 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40410 | Film No.: 211505622
SIC: 6770 Blank Checks